Max Delbrück Center
Register
Register
Register

EPO Berlin-Buch GmbH

University / Research Organisation

www.epo-berlin.comBerlin, Germany

About

EPO is a preclinical contract research organization (CRO) offering customized pre-clinical oncology and immuno-oncology services for the development of novel anti-cancer drugs.

Our portfolio includes >1000 well characterized PDX models, cell line-derived xenograft- as well as syngeneic tumor models. EPO also has long term experience in the establishment of humanized models and has been running studies in these for over a decade.

EPO has been founded in 1997 as a spin-off from the MDC in Berlin-Buch.

Social media

Disease Area

Cancer

Biomedical Research, Medicine, Human Health

Drug Target DiscoveryBiomarker DiscoveryCell TherapyRNA-based Therapy

Technology

Data science, AI / Machine learningPersonalized disease models

Representatives

Head of Business Development

EPO Berlin-Buch GmbH